Given that the other IHC hypoxic markers, a crucial factor of radioresistance, were not significantly related to MCL1 amplification in our data, it would be interesting to clarify whether the MCL1 copy number gain was driven by tumor hypoxia, or whether the MCL1 amplification-related cancer cell survival resulted in tumor hypoxia. Here, MCL1 is linked to neoplasm.